Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer

The synergistic effects of new generation chemotherapeutics when combined with cisplatin have encouraged the development of new triplet combination regimens in the treatment of advanced non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the feasibility of triplet chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: TAS, FARUK, SEN, FATMA, GUNEY, NESE, KESKIN, SERKAN, CAMLICA, HAKAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678590/
https://www.ncbi.nlm.nih.gov/pubmed/23761836
http://dx.doi.org/10.3892/ol.2013.1205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678590/
https://www.ncbi.nlm.nih.gov/pubmed/23761836
http://dx.doi.org/10.3892/ol.2013.1205

Ejemplares similares